Applied Genetic Technologies Corp (AGTC) Covered Calls

You can sell covered calls on Applied Genetic Technologies Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AGTC (prices last updated Fri 4:16 PM ET):

Applied Genetic Technologies Corp (AGTC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.25 -0.22 3.23 3.35 341K - 0.0B
Covered Calls For Applied Genetic Technologies Corp (AGTC)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 2.5 0.05 3.30 -24.2% -1104.1%
Jan 18 2.5 0.10 3.25 -23.1% -234.2%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which is a disease of the central nervous system and otology. It has collaboration agreements with Biogen MA, Inc., 4D Molecular Therapeutics, Synpromics Limited, and Bionic Sight, LLC, as well as the University of Florida Research Foundation. The company was founded in 1999 and is headquartered in Alachua, Florida.